• Citer

Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study

par Da Silva Lopes, André Manuel;Colomer-Lahiguera, Sara;Mederos Alfonso, Nuria;Aedo-Lopez, Veronica;Spurrier-Bernard, Gilly;Tolstrup, Lærke Kjær;Pappot, Helle;Aspeslagh, Sandrine;Rogiers, Anne ;Neyns, Bart;Haanen, John;Mitchell, Sandra S.A.;Addeo, Alfredo;Michielin, Olivier;Eicher, Manuela
Référence European journal of cancer, 157, page (225-237)
Publication Publié, 2021-11

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study
Auteur:	Da Silva Lopes, André Manuel; Colomer-Lahiguera, Sara; Mederos Alfonso, Nuria; Aedo-Lopez, Veronica; Spurrier-Bernard, Gilly; Tolstrup, Lærke Kjær; Pappot, Helle; Aspeslagh, Sandrine; Rogiers, Anne; Neyns, Bart; Haanen, John; Mitchell, Sandra S.A.; Addeo, Alfredo; Michielin, Olivier; Eicher, Manuela
Informations sur la publication:	European journal of cancer, 157, page (225-237)
Statut de publication:	Publié, 2021-11
Sujet CREF:	Cancérologie
Mots-clés:	Delphi consensus
	Immune checkpoint inhibitors
	Patient-reported outcomes
	PRO-CTCAE™
	Symptomatic immune-related adverse events
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/j.ejca.2021.08.026
	info:pii/S0959804921005530
	info:scp/85114903057
	info:pmid/34536946